Artikler med mandater om offentlig tilgang - Daniel SW TanLes mer
Ikke tilgjengelige noe sted: 20
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Y Simoni, E Becht, M Fehlings, CY Loh, SL Koo, KWW Teng, JPS Yeong, ...
Nature 557 (7706), 575-579, 2018
Mandater: A*Star, Singapore, National Medical Research Council, Singapore
Targeted therapies for lung cancer patients with oncogenic driver molecular alterations
AC Tan, DSW Tan
Journal of Clinical Oncology 40 (6), 611-625, 2022
Mandater: National Medical Research Council, Singapore
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
JF Gainor, G Curigliano, DW Kim, DH Lee, B Besse, CS Baik, ...
The lancet oncology 22 (7), 959-969, 2021
Mandater: US National Institutes of Health
Concurrent chemo-radiation with or without induction gemcitabine, carboplatin, and paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma
T Tan, WT Lim, KW Fong, SL Cheah, YL Soong, MK Ang, QS Ng, D Tan, ...
International Journal of Radiation Oncology* Biology* Physics 91 (5), 952-960, 2015
Mandater: Cancer Research UK
Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development
DSW Tan, GV Thomas, MD Garrett, U Banerji, JS De Bono, SB Kaye, ...
The Cancer Journal 15 (5), 406-420, 2009
Mandater: Cancer Research UK
Revisiting neoadjuvant therapy in non-small-cell lung cancer
SPL Saw, BH Ong, KLM Chua, A Takano, DSW Tan
The Lancet Oncology 22 (11), e501-e516, 2021
Mandater: National Medical Research Council, Singapore
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer
GGY Lai, TH Lim, J Lim, PJR Liew, XL Kwang, R Nahar, ZW Aung, ...
Journal of clinical oncology 37 (11), 876-884, 2019
Mandater: National Medical Research Council, Singapore
Anti-cancer drug resistance: understanding the mechanisms through the use of integrative genomics and functional RNA interference
DSW Tan, M Gerlinger, BT Teh, C Swanton
European Journal of Cancer 46 (12), 2166-2177, 2010
Mandater: Cancer Research UK
Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 study
DSW Tan, NB Leighl, GJ Riely, JCH Yang, LV Sequist, J Wolf, T Seto, ...
The Lancet Respiratory Medicine 8 (6), 561-572, 2020
Mandater: National Medical Research Council, Singapore
Vitamin E isoform γ-tocotrienol protects against emphysema in cigarette smoke-induced COPD
HY Peh, WSD Tan, TK Chan, CW Pow, PS Foster, WSF Wong
Free Radical Biology and Medicine 110, 332-344, 2017
Mandater: National Medical Research Council, Singapore
Non-small-cell lung cancer
LEL Hendriks, J Remon, C Faivre-Finn, MC Garassino, JV Heymach, ...
Nature Reviews Disease Primers 10 (1), 71, 2024
Mandater: National Institute for Health Research, UK
From irreversible to reversible covalent inhibitors: Harnessing the andrographolide scaffold for anti-inflammatory action
QTN Tran, DWS Tan, WSF Wong, CLL Chai
European Journal of Medicinal Chemistry 204, 112481, 2020
Mandater: National Research Foundation, Singapore
Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors
LR Molife, SM Rudman, S Alam, DSW Tan, H Kristeleit, G Middleton, ...
Cancer chemotherapy and pharmacology 72, 1213-1222, 2013
Mandater: Cancer Research UK
A study of the pattern of hospital admissions in a specialist Phase I oncology trials unit: Unplanned admissions as an early indicator of patient attrition
AT Brunetto, JE Ang, D Olmos, D Tan, J Barriuso, HT Arkenau, TA Yap, ...
European journal of cancer 46 (15), 2739-2745, 2010
Mandater: Cancer Research UK
Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non–Small …
AC Tan, SPL Saw, J Chen, GGY Lai, HN Oo, A Takano, DPX Lau, ...
JCO Precision Oncology 6, e2200278, 2022
Mandater: National Medical Research Council, Singapore
Dynamic contrast-enhanced computed tomography in metastatic nasopharyngeal carcinoma: reproducibility analysis and observer variability of the distributed parameter model
QS Ng, CH Thng, WT Lim, S Hartono, YL Thian, PS Lee, DSW Tan, ...
Investigative Radiology 47 (1), 5-10, 2012
Mandater: US National Institutes of Health
Economic evaluations of imaging biomarker-driven companion diagnostics for cancer: a systematic review
S Liu, DSW Tan, N Graves, AM Chacko
Applied Health Economics and Health Policy 21 (6), 841-855, 2023
Mandater: A*Star, Singapore
Liquid biopsies for cancer genotyping: Coming of age?
A Jacobsen Skanderup, SF Ang, DSW Tan
Clinical Cancer Research 29 (8), 1381-1383, 2023
Mandater: National Medical Research Council, Singapore
Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for BRCA Methylation Testing?
TJ Tan, JL Fink, TK Tay, B Jaradi, N Stone, P Waring, KM Koo, PH Tan, ...
JCO Precision Oncology 6, e2200309, 2022
Mandater: National Medical Research Council, Singapore
Commentary: Stereotactic Body Radiotherapy for Spinal Metastases at the Extreme Ends of the Spine: Imaging-Based Outcomes for Cervical and Sacral Metastases
B Vellayappan, D Tan, M Foote, KJ Redmond, SS Lo
Neurosurgery 85 (5), E804-E805, 2019
Mandater: National Medical Research Council, Singapore
Informasjon om publisering og finansiering fastsettes automatisk av et datamaskinprogram